Bio-Techne Corp - Common Stock · Transaction Apr 8, 2026 · Filed May 6, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · TECH
-0.06% · -$0.0400 · Vol 5.0M
Market closed · last close 4:00 PM ET · price as of 16:21:10 ET
Bio-Techne Corp
Life Sciences Tools & Services
$72.37
Follow $TECH
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $TECH by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · TECH
MethodologyTECH
Bio-Techne Corp
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
52/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is TECH moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Bio-Techne Corp
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Listed since
1989
Employees
3K
Country
US
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$72.41
Day high
$72.44
Day low
$72.26
Previous close
$72.41
52W high
$72.48
-0.15% from high
52W low
$43.30
100% of range
Market cap
$11.4B
P/E
76.99×
EPS
$0.9400
Beta
0.64
Shares out
156.8M
Volume
5M
1.83× rel vol
Avg volume
2.8M
VWAP
$72.38
Price history computed in-house
1W
+0.35%
1M
+0.12%
3M
+24.91%
1Y
+36.16%
YTD
+23.06%
SMA 50 $72.10 · above
SMA 200 $61.46 · above
52W position 100%
TECH overview
Related filings and maps
Public disclosures
Congress activity in TECH
Official filing ↗
Bio-Techne Corp - Common Stock · Transaction Mar 26, 2026 · Filed Apr 6, 2026 · $1,001 to $15,000
Bio-Techne Corp - Common Stock · Transaction Feb 24, 2026 · Filed Mar 10, 2026 · $1,001 to $15,000
Bio-Techne Corp - Common Stock · Transaction Jan 28, 2026 · Filed Feb 2, 2026 · $1,001 to $15,000
Bio-Techne Corp - Common Stock · Transaction Dec 5, 2025 · Filed Jan 5, 2026 · $1,001 to $15,000
Federal contracts
TECH contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TECH in this window.
Lobbying spend
TECH lobbying filings, year to date.
Registered lobbying filings matched to Bio-Techne Corp.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TECH in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for TECH.
Options
Sovereign unlock shows live options positioning for TECH.